<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>CCI approves subscription of compulsorily convertible preference shares of API Holdings Limited by Goldman Sachs India AIF Scheme-1 and Goldman Sachs India Alternative Investment Trust AIF Scheme-2</title>
    <link>https://www.taxtmi.com/news?id=27203</link>
    <description>Approval was granted for the subscription of compulsorily convertible preference shares of API Holdings Limited by two Goldman Sachs India alternative investment fund schemes managed by Goldman Sachs (India) Alternative Investment Management Private Limited, constituting a notifiable combination under the competition framework; the Target is the parent of a group operating across pharmaceutical distribution, medical devices, OTC products, diagnostics and tele medical consultation services in India.</description>
    <language>en-us</language>
    <pubDate>Wed, 31 Jan 2024 15:37:41 +0530</pubDate>
    <lastBuildDate>Wed, 31 Jan 2024 15:37:41 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=741911" rel="self" type="application/rss+xml"/>
    <item>
      <title>CCI approves subscription of compulsorily convertible preference shares of API Holdings Limited by Goldman Sachs India AIF Scheme-1 and Goldman Sachs India Alternative Investment Trust AIF Scheme-2</title>
      <link>https://www.taxtmi.com/news?id=27203</link>
      <description>Approval was granted for the subscription of compulsorily convertible preference shares of API Holdings Limited by two Goldman Sachs India alternative investment fund schemes managed by Goldman Sachs (India) Alternative Investment Management Private Limited, constituting a notifiable combination under the competition framework; the Target is the parent of a group operating across pharmaceutical distribution, medical devices, OTC products, diagnostics and tele medical consultation services in India.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 31 Jan 2024 15:37:41 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=27203</guid>
    </item>
  </channel>
</rss>